Literature DB >> 1001846

Regulation of brittle diabetics by a pre-planned insulin infusion programme.

T Deckert, B Lorup.   

Abstract

Eleven brittle diabetics, mean duration 11.5 years, all treated with highly purified porcine NPH insulin twice daily, were placed on highly purified porcine regular insulin 4 times daily for 2 days. Thereafter pre-planned intravenous insulin infusion was started. Insulin in an amount corresponding to the daily insulin requirement was infused by a mobile electric infusion pump at precalculated rates between 30 and 7 ml/hour during 2 days. The patients were ambulatory. Capillary blood glucose was taken every 30 min after meals and every two hours during the night. After an equilibration period of 7 hours, blood glucose fluctuations were in the physiological range in nearly all patients during the infusion period. [Only 1.3% of the blood samples showed glucose levels lower than 2.5 mmol/l and 2.9% levels exceeding 10.0 mmol/l during the infusion days]. Mean blood glucose (MBG) was 6.0 +/- 0.9 mmol/l (mean +/- s.d.), the standard deviation of MBG was 1.8 +/- 0.5 mmol/l, the mean amplitude of blood glucose excursions (MAGE) 4.7 +/- 1.4 mmol/l, and glucosuria 3.1 +/- 3.9 g/day. All these data of glucose homeostasis were significantly lower during the infusion days. The incidence of hypoglycaemic attacks was low (0.32/patient/day) and not significantly higher than during NPH treatment. It is concluded that near normal blood glucose fluctuations can be achieved in brittle diabetics by preplanned insulin infusion without blood glucose monitoring.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1001846     DOI: 10.1007/bf01220633

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  15 in total

1.  The effect of metabolic regulation on microvascular permeability to small and large molecules in short-term juvenile diabetics.

Authors:  H H Parving; I Noer; T Deckert; P E Evrin; S L Nielsen; J Lyngsoe; C E Mogensen; M Rorth; P A Svendsen; J Trap-Jensen; N A Lassen
Journal:  Diabetologia       Date:  1976-05       Impact factor: 10.122

2.  Immunoreactive growth hormone in plasma and urine in juvenile diabetics before and during initial insulin treatment.

Authors:  K F Hanssen
Journal:  Acta Endocrinol (Copenh)       Date:  1974-01

3.  One to five days of continuous intravenous insulin infusion on seven diabetic patients.

Authors:  G Slama; M Hautecouverture; R Assan; G Tchobroutsky
Journal:  Diabetes       Date:  1974-09       Impact factor: 9.461

4.  Radioimmunoassays employing immunosorbents.

Authors:  L Wide
Journal:  Acta Endocrinol Suppl (Copenh)       Date:  1969

5.  Mean amplitude of glycemic excursions, a measure of diabetic instability.

Authors:  F J Service; G D Molnar; J W Rosevear; E Ackerman; L C Gatewood; W F Taylor
Journal:  Diabetes       Date:  1970-09       Impact factor: 9.461

6.  [Insulin adsorption to infusion materials].

Authors:  B Enk; C Eff
Journal:  Ugeskr Laeger       Date:  1976-02-16

7.  Dietary fats, the diurnal blood lipids and ketones in juvenile diabetes.

Authors:  G C Sterky; B E Persson; Y A Larsson
Journal:  Diabetologia       Date:  1966-06       Impact factor: 10.122

8.  Glucose, insulin, pancreatic glucagon and glucagon-like immunoreactive materials in the plasma of normal and diabetic children. Effect of the initial insulin treatment.

Authors:  T Matsuyama; W H Hoffman; J C Dunbar; N L Foà; P P Foà
Journal:  Horm Metab Res       Date:  1975-11       Impact factor: 2.936

9.  The essential role of glucagon in the pathogenesis of diabetes mellitus.

Authors:  R H Unger; L Orci
Journal:  Lancet       Date:  1975-01-04       Impact factor: 79.321

10.  A model of the kinetics of insulin in man.

Authors:  R S Sherwin; K J Kramer; J D Tobin; P A Insel; J E Liljenquist; M Berman; R Andres
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808

View more
  24 in total

1.  [Pre-programmed continuous insulin infusion for the control of diabetes mellitus (author's transl)].

Authors:  K D Hepp; E Buchholz; R Renner; H J von Funcke; H Mehnert
Journal:  Klin Wochenschr       Date:  1979-02-01

2.  Evaluation of exogenous insulin homoeostasis by the artificial pancreas in insulin-dependent diabetes.

Authors:  J Mirouze; J L Selam; T C Pham; D Cavadore
Journal:  Diabetologia       Date:  1977-05       Impact factor: 10.122

3.  The dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus: magnitude, frequency, variability, and dependency on glucose counterregulation and insulin sensitivity.

Authors:  G Perriello; P De Feo; E Torlone; C Fanelli; F Santeusanio; P Brunetti; G B Bolli
Journal:  Diabetologia       Date:  1991-01       Impact factor: 10.122

4.  Continuous subcutaneous insulin infusion:good blood glucose control for up to 4 days.

Authors:  J C Pickup; H Keen; J A Parsons; K G Alberti
Journal:  Diabetologia       Date:  1979-06       Impact factor: 10.122

5.  Controlled release micropump for insulin administration.

Authors:  M V Sefton; H M Lusher; S R Firth; M U Waher
Journal:  Ann Biomed Eng       Date:  1979       Impact factor: 3.934

6.  The value of good control.

Authors:  J C Pickup; H Keen
Journal:  Ir J Med Sci       Date:  1979       Impact factor: 1.568

7.  Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus by decreasing hepatic (and extrahepatic) sensitivity to insulin in the absence of insulin waning.

Authors:  G Perriello; P De Feo; E Torlone; C Fanelli; F Santeusanio; P Brunetti; G B Bolli
Journal:  Diabetologia       Date:  1990-01       Impact factor: 10.122

8.  Pharmacokinetic approach for reconstruction of predetermined plasma insulin profiles by continuous subcutaneous insulin infusion in depancreatized dogs.

Authors:  H Hirayama; Y Kasuya; T Kobayashi; T Itoh; A Yagishita; T Katakura; K Isono
Journal:  J Pharmacokinet Biopharm       Date:  1983-12

9.  The effect of continuous subcutaneous insulin infusion and conventional insulin regimes on 24-hour variations of blood glucose and intermediary metabolites in the third trimester of diabetic pregnancy.

Authors:  J M Potter; J P Reckless; D R Cullen
Journal:  Diabetologia       Date:  1981-12       Impact factor: 10.122

10.  Improvement of glucose homeostasis in insulin-dependent diabetics using a miniature insulin infusion pump with a fixed profile.

Authors:  K Køolendorf; J Bojsen; B Løorup
Journal:  Diabetologia       Date:  1980       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.